SANTOVITO LAB - TRANSLATIONAL VASCULAR THERAPY

SANTOVITO LAB

The translational vascular therapy research group studies the role of epigenetics and autophagy in atherosclerosis and cardiovascular disease. 


  • In particular, the research focuses on understanding the molecular mechanisms behind canonical and noncanonical features of microRNA function and trafficking, the interaction of multiple epigenetic regulatory mechanisms, and how they contribute to communication between stromal and immune cells within and beyond the vessel wall. 
  • The goal is to identify molecular mechanisms that can be exploited as therapeutic targets or diagnostic/prognostic markers to improve the standard of care for atherosclerosis and cardiovascular diseases.

Donato Santovito

LATEST NEWS FROM THE LAB

Congratulations to Donato Santovito for Outstanding Achievement Award 

17 Sep 2025

The Outstanding Achievement Award from the ESC Council for Basic Cardiovascular Science (CBCS) honors two basic researchers in the early stage of their career with outstanding accomplishments.

Atherosclerosis: RNA fragment creates prospect for new therapies

1 Nov 2023 | News | Publication

SCIENCE TRANSL.MED 2023 ➤ IPEK researchers have demonstrated for the first time what role a specific microRNA plays in atherosclerosis – and how it manages to intervene in this signaling pathway.

How a miRNA binds and inhibits Caspase-3 to confer vascular integrity

SCIENCE TRANSLATIONAL MEDICINE 2020  ➤ IPEK scientists have discovered a hitherto unknown molecular function of a specific microRNA that preserves integrity of the endothelium and reduces the risk of…